Phio Pharmaceuticals Corp. (PHIO) stock
PHIONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.81−0.00 (-0.17%)
Close on Nov 12, 2026Market cap $9.43MP/E –Yield –
Phio Pharmaceuticals profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Phio Pharmaceuticals's profit margin for the twelve months ending Dec 31, 2019 was -42419.0%. For fiscal 2019 it was -42419.0%, against -5333.3% the year before. The highest annual figure on record is -5244.4% in fiscal 2013.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | -42419.0% | −37085.7 |
| FY2018 | Dec 31, 2018 | -5333.3% | +77680.0 |
| FY2017 | Dec 31, 2017 | -83013.3% | −35676.5 |
| FY2016 | Dec 31, 2016 | -47336.8% | −17269.2 |
| FY2015 | Dec 31, 2015 | -30067.6% | −24823.3 |
| FY2013 | Dec 31, 2013 | -5244.4% | +8034.0 |
| FY2012 | Dec 31, 2012 | -13278.4% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2019 | Mar 31, 2019 | -10090.5% | +3256.2 |
| Q3 FY2018 | Sep 30, 2018 | -2619.3% | – |
| Q2 FY2018 | Jun 30, 2018 | -3277.6% | – |
| Q1 FY2018 | Mar 31, 2018 | -9734.8% | – |
| Q4 FY2017 | Dec 31, 2017 | -13346.7% | – |
See a number that looks wrong?